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Studies report that football players have high blood pressure (BP) and increased cardiovascular risk. There are over 70,000 NCAA
football players and 450 Division III schools sponsor football programs, yet limited research exists on vascular health of athletes.
This study aimed to compare vascular and cardiovascular health measures between football players and nonathlete controls.
Twenty-three athletes and 19 nonathletes participated. Vascular health measures included flow-mediated dilation (FMD) and
carotid artery intima-media thickness (IMT). Cardiovascular measures included clinic and 24 hr BP levels, body composition,
VO
2max, and fasting glucose/cholesterol levels. Compared to controls, football players had a worse vascular and cardiovascular
profile. Football players had thicker carotid artery IMT (0.49 ± 0.06mm versus 0.46 ± 0.07mm) and larger brachial artery diameter
during FMD (4.3 ± 0.5mm versus 3.7 ± 0.6mm), but no difference in percent FMD. Systolic BP was significantly higher in football
players at all measurements: resting (128.2 ± 6.4mmHg versus 122.4 ± 6.8mmHg), submaximal exercise (150.4 ± 18.8mmHg
versus 137.3 ± 9.5mmHg), maximal exercise (211.3 ± 25.9mmHg versus 191.4 ± 19.2mmHg), and 24-hour BP (124.9 ± 6.3mmHg
versus 109.8 ± 3.7mmHg). Football players also had higher fasting glucose (91.6 ± 6.5mg/dL versus 86.6 ± 5.8mg/dL), lower HDL
(36.5±11.2mg/dL versus 47.1±14.8mg/dL), and higher body fat percentage (29.2±7.9% versus 23.2±7.0%). Division III collegiate
football players remain an understudied population and may be at increased cardiovascular risk.
1. Introduction
Hypertension and cardiovascular disease (CVD) are global
health problems [1, 2]. High blood pressure (BP) has a
direct relationship with increased body weight and risk
of cardiac incidents and is also prevalent in professional
and collegiate football players [3–5]. It is assumed that
the increased physical activity the athletes perform leads
to improved cardiac health, but studies report increases in
CVD risk. Studies have found that Division I football players
have high body fat, metabolic disease, and high resting BP
levels and that BP increases over competitive seasons [6–
8]. Separate research [9] has shown that Division II athletes
have high BP, increased body mass index (BMI), and low
high density lipoprotein (HDL) levels. There are over 70,000
NCAA football players and nearly 450 Division III schools
sponsor football programs, yet research is lacking in health of
Division III football players, and there is a paucity of research
in vascular health of athletes overall [6–9].
Vascular health is related to CVD and can be assessed
through a number of clinical modalities, including flow-
mediated dilation (FMD) and carotid artery intima-media
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thickness (IMT) [10]. FMD is a noninvasive test, an index of
NO-mediated endothelial-dependent function in humans [11,
12]. Measuring carotid artery IMT assesses vascular remod-
eling by quantifying thickness of the smooth muscle layer
[13, 14]. Previously we have reported [15] that brachial artery
FMD increased and carotid artery IMT decreased with a six-
month aerobic exercise program, suggesting improvements
in vascular health. However, clinical research in vascular
health of athletes remains understudied. Lower FMD has
been measured in professional athletes in one study, while
another study found no difference in FMD between Division
I football players and controls [8, 16]. Increased arterial stiff-
ness was found [16] in Division I football players compared
to controls. Other research [17] has found that professional
football players have similar carotid artery IMT values to
matched controls. To the best of our knowledge, no study has
examined vascular health in Division III football players.
The purpose of this study was to compare vascular health
between football players and controls and to examine changes
in cardiovascular health over a season, providing for the first
time a cardiovascular health profile in Division III football
players.
2. Methods
2.1. Participants. Football players were recruited from Ursi-
nus College NCAADivision III football team and were tested
before and after season.A control group composed of nonath-
lete males was recruited and matched to the football players
by age and by prior physical activity level (number of times
reported exercise per week). The control group was tested
at one point during the middle of the football season. All
preseason exercise testing was completed before the football
training camp, and fasting studies were completed in the first
week of camp. All postseason testing was completed within
two weeks of the end of the football season. Vascular studies
and 24-hour Ambulatory Blood Pressure (ABP) measures
were collected once during the middle of the season. Only
players who completed both pre- and postseason testing were
included in this analysis. For a subanalysis, players were
stratified into two groups based on playing position: lineman
(LM) and nonlineman (NLM).
Specific criteria for inclusion for all participants were
as follows: being nondiabetic, nonsmoking, no medications
that affect cardiovascular hemodynamics, no more than
one antihypertensive medication, and no evidence or his-
tory of CVD, hypercholesterolemia, or renal disease. Each
participant gave written informed consent and completed
a health and exercise history questionnaire. The protocol
was approved by the Ursinus College Institutional Review
Board, and all procedures were in accordance with the ethical
standards of the Helsinki Declaration.
2.2. Blood Pressure Measurements. Clinic BP measurements
were obtained in accordance with JNC-7 guidelines [2] on
three separate visits in a quiet (5min rest), temperature con-
trolled room, using an aneroid sphygmomanometer (Medline
Industries, Mundelein, IL). For accurate readings, proper size
BP cuff was used for measurements, based on the arm size of
participant. BP measurements were performed in triplicate
with the average of the three values used as the representative
BP for that visit.Themean systolic BP and diastolic BP across
the three visits are reported as the clinic BP.
Twenty-four-hour ABP monitoring was completed using
a noninvasive portable BP monitor (SpaceLabs, Redmond,
WA), as previously [18] described. Monitoring began in the
morning of each participant’s typical day. BP measures were
obtained at 30min intervals during the day and 60min
intervals at night. The following morning, each participant
was asked to list their awake hours (daytime BP) and sleep
hours (nighttime BP). Participant data was included in
final analysis if more than 80% of the measurements were
collected. Mean values were calculated for 24-hour average,
for daytime, and for nighttime time-frames.
2.3. Glucose/Cholesterol Measurements. Fasting plasma glu-
cose and cholesterol levels were measured using the Alere
Cholestech LDXⓇ lipid profile system (San Diego, CA).
Blood was obtained by fingerstick using a 35 𝜇L lithium
heparin-coated capillary tube and tested immediately. Lipid
profile cassettes were inserted into the Cholestech to analyze
blood samples. Previously, fingerstick lipid profile valueswere
correlated (𝑟 > 0.95) with venous plasma values measured
in clinical diagnostic laboratories (Alere), and this meets
the National Cholesterol Education Program criteria [19] for
agreement between methods.
2.4. Body Composition Measurements. Body composition
was measured by whole-body bioelectrical impedance (BIA)
using the single frequency impedance instrument (Imped-
iMed DF50, San Diego, CA) following an overnight fast in a
quiet, temperature controlled room. Participants were asked
to refrain from salty foods, exercise, medication, alcohol,
and caffeine for at least 10 hours prior to the test. Height
and weight were measured using a calibrated electronic scale
without shoes. BIA was measured in accordance with the
manufacturer’s instructions at 50 kHz on the right side of the
body. Two electrodes were placed on the dorsal right hand
and foot while the athletes were lying in a supine position.
Three measurements were taken, and the mean values of
impedance, phase, resistance, and reactance were used for
calculations of total fat and fat-free mass.
2.5. VO2 Exercise Test. A maximal graded exercise test was
performed to determine cardiorespiratory fitness. The Bruce
protocol was performed with continuous measurement of
breath-by-breath gas sampling to measure oxygen consump-
tion (VO
2
) using a calibrated metabolic cart (TrueOne 2400,
ParvoMedics, Sandy, UT). ECG was continuously monitored
(Nasiff CardioCard, Central Square, NY). BP, heart rate, and
perceived exertionweremeasured at each stage.The treadmill
test was completed using termination criteria according to
guidelines [20].
2.6. Blood Vessel Ultrasound Measurements. Brachial artery
diametermeasurements using flow-mediated dilation (FMD)
were collected following an overnight fast in a quiet,
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temperature controlled room. Each participant underwent
an acclimation phase (20min) to obtain a hemodynamic
steady state. Heart rate was continuously monitored using
a 3-lead ECG, and BP measurements were taken in the
left arm to confirm a steady state. A 5 × 84 cm automatic
cuff (E-20 rapid cuff inflator; D.E. Hokanson Bellevue, WA)
was placed around the right forearm distal to the olecranon
process following established guidelines [21] for assessing
FMD. Baseline images were obtained longitudinally 2 to
10 cm above the antecubital fossa by 2D high resolution
ultrasound system, using a 5 to 12MHzmultifrequency linear
array transducer. Once a satisfactory image was obtained,
the right arm was secured, the position was marked, and the
transducer was stabilized using a clamp. Minor corrections
of transducer placement were made to maintain optimal
imaging. Doppler velocity was measured via ultrasound,
Doppler flow signals were corrected at an insonation angle
of 60∘, and measurements were performed with the sample
volume placed mid-artery. Measurements were recorded
for 30 seconds at baseline; then the automatic forearm
cuff was then inflated to 250mmHg and maintained for 5
minutes. Diameter and velocity recordings resumed before
cuff deflation and continued for 2 minutes thereafter, while
postischemia images were collected. Ultrasound FMD videos
were recorded using the GE Logiq E (GE Medical Systems,
Chicago, IL) and downloaded to a separate computer using
Movavi Video Editor (Movavi, St Louis, MO). Arterial
diameters were analyzed using the Brachial Analyzer for
Research (Medical Imaging Applications, Coralville, IA).
The highest 10-second interval throughout the 2-minute
collection period represented the peak hyperemic diameter.
Velocity and diameter measurements were converted to local
shear stress using the following equation [22]: shear stress =
8 × 𝜇 × 𝑉
𝐻
/𝐷BL, where 𝜇 is blood viscosity, assumed to
be 0.035 dyne seconds/cm2, 𝑉
𝐻
is the peak posthyperemia
velocity, and 𝐷BL represents the baseline diameter. FMD
reported is the percent increase in diameter frombaseline and
is calculated as FMD = (peak hyperemic diameter – baseline
diameter)/baseline diameter. The same operator performed
all FMDmeasurements.
On the same day as FMD measurements, carotid artery
IMT images were recorded and automatically calculated as
previously [15] described. Images were obtained and mea-
surementsmade using the GE Logiq E ultrasound system and
automated calculation software (Auto-IMT Software Option,
GE Medical Systems, Chicago, IL). Three measures were
collected of the posterior wall of the common carotid artery,
as per established guidelines [13]. The average of all readings
was calculated, and this value is reported.
2.7. Statistical Analyses. Data are expressed as mean ± the
standard deviation (SD). Distribution of all variables was
examined using the Shapiro-Wilk test of normality. Nonpara-
metric tests were usedwhen appropriate. Pre- and postseason
values were compared using the paired samples 𝑡-test or
the paired samples Wilcoxon signed-rank test. Independent
𝑡-tests were used to compare differences between football
players and controls and between LM and NLM. Pearson
Table 1: Comparison between football players and control.
Variable Football players Control
Age 19.8 ± 1.0 20.8 ± 2.0
Height (cm) 178.8 ± 4.6 178.0 ± 6.1
Body weight (kg) 103.8 ± 20.6 78.7 ± 10.6
Body fat (%) 29.2 ± 7.9 23.2 ± 7.0∗
SBP (mmHg) 128.2 ± 6.4 122.4 ± 6.8∗
DBP (mmHg) 74.8 ± 4.1 73.9 ± 6.3
Glucose (mg/dL) 91.6 ± 6.5 86.6 ± 5.8∗
Total cholesterol (mg/dL) 136.6 ± 23.9 157.1 ± 36.8
HDL (mg/dL) 36.5 ± 11.2 47.1 ± 14.8∗
Triglycerides (mg/dL) 98.2 ± 55.2 102.1 ± 60.5
LDL (mg/dL) 83.2 ± 18.2 97.3 ± 33.9
VO
2max (mL/kg/min) 42.4 ± 8.4 49.6 ± 7.8
∗
Baseline BA diameter (mm) 4.3 ± 0.5 3.7 ± 0.6∗
FMD (%) 8.5 ± 4.5 9.9 ± 3.3
FMD/shear 0.61 ± 0.3 0.60 ± 0.3
IMT (mm) 0.496 ± 0.06 0.462 ± 0.07∗
Data are presented as mean ± SD. ∗Post hoc significantly different from
control,𝑃 < 0.05. SBP, systolic blood pressure; DBP, diastolic blood pressure;
HDL, high density lipoprotein; LDL, low density lipoprotein; VO2max,
oxygen consumption; BA, brachial artery; FMD, flow-mediated dilation;
IMT, intima-media thickness.
correlation was used to determine if there were relationships
between the variables and was further examined by linear
regression analysis. Statistical significancewas set at𝑃 < 0.05.
All statistical analyses were performed using SPSS version
19.0 (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Participants. Twenty-seven football players were
recruited from the Ursinus College NCAA Division III
football team. Due to injuries or scheduling issues, four
athletes did not complete postseason testing and were
excluded from the current analysis. Thus 23 athletes (12 LM
and 11NLM) were included in this analysis. Nineteen
physically active noncollegiate athlete males were recruited
from the college. They were matched to the football players
by age (20.8 ± 2.0 yrs control, 19.8 ± 1.0 yrs football players)
and by physical activity level (4.9 ± 1.5 times exercise/week
control, 5.6 ± 0.9 times exercise/week football players).
3.2. Vascular Health and Blood Pressure. Table 1 shows the
comparison of vascular and cardiovascular health measures
between football players and matched controls. Football
players had thicker carotid artery IMT compared to the
control group (0.496 ± 0.06mm versus 0.462 ± 0.07mm,
𝑃 < 0.05). Football players also had larger baseline diameter
(4.3±0.5mmversus 3.7±0.6mm,𝑃 < 0.05) and peak brachial
diameter during FMD (4.7 ± 0.6mm versus 4.1 ± 0.7mm,
𝑃 < 0.05), but percent change in FMD was similar between
groups (8.5 ± 4.5% versus 9.9 ± 3.3%, 𝑃 = 0.93). Football
players also had higher fasting glucose levels (91.6±6.5mg/dL
versus 86.6±5.8mg/dL,𝑃 < 0.05), higher body fat percentage
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Table 2: Football player responses over a season.
Nonlineman Lineman
Preseason Postseason Preseason Postseason
Age 19.9 ± 1.1 — 19.8 ± 0.9 —
# Times exercise/week 5.8 ± 1.0 — 5.6 ± 0.9 —
# Games played 6.4 ± 3.0 — 4.9 ± 4.2 —
Height (cm) 176.0 ± 4.1 — 180.8 ± 4.2 —
Body weight (kg) 84.5 ± 4.9 83.2 ± 4.6∗ 117.0 ± 14.1∗∗ 117.1 ± 14.7∗∗
Clinic SBP (mmHg) 130.2 ± 11.6 133.0 ± 6.6 129.0 ± 6.8 132.4 ± 7.8
Clinic DBP (mmHg) 75.1 ± 4.9 74.3 ± 7.5 76.4 ± 3.9 74.1 ± 4.9
Glucose (mg/dL) 89.7 ± 6.0 86.7 ± 6.9∗ 93.7 ± 6.5 93.3 ± 9.0
Total cholesterol (mg/dL) 137.0 ± 29.0 141.4 ± 24.8 133.9 ± 16.7 142.3 ± 22.2
HDL (mg/dL) 42.0 ± 11.1 46.7 ± 11.2 32.2 ± 9.5∗∗ 39.0 ± 9.0∗
Triglycerides (mg/dL) 89.3 ± 31.8 93.0 ± 23.6 107.6 ± 69.0 126.3 ± 83.2∗
LDL (mg/dL) 83.6 ± 18.1 91.6 ± 13.3 83.7 ± 15.8 82.1 ± 15.8
Body fat (%) 23.2 ± 2.7 25.9 ± 5.0 34.2 ± 7.3∗∗ 31.1 ± 6.7∗∗
VO
2max (mL/kg/min) 48.9 ± 5.2 49.0 ± 4.4 37.1 ± 6.5
∗∗ 38.3 ± 6.5∗∗
Data are mean ± SD. ∗𝑃 < 0.05 from preseason to postseason. ∗∗𝑃 < 0.05 between groups. SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL,
high density lipoprotein; LDL, low density lipoprotein; VO2, volume of oxygen consumption.
(29.2 ± 7.9% versus 23.2 ± 7.0%, 𝑃 < 0.05), and lower fasting
HDL levels (36.5 ± 11.2mg/dL versus 47.1 ± 14.8mg/dL, 𝑃 <
0.05) compared to controls. All of these markers indicate a
worse vascular and cardiovascular health profile in football
players compared to controls.
Isolated systolic BP is associated with pathophysiology, is
the most common form of hypertension, and is the focus of
risk stratification [23]. For every measurement, systolic BP
was higher in football players compared to controls. Figure 1
shows that systolic BP was higher in football players at rest,
during a full 24-hour period, at night, during all submaximal
exercise stages, and at maximum exercise (all 𝑃 < 0.05).
There was no difference between the groups in any measure
for diastolic BP levels.
3.3. Changes in Health over the Football Season. Table 2
displays changes in cardiovascular health for the football
players following a collegiate season. In the entire group,
only HDL increased over the season (36.5 ± 11.2 to 42.4 ±
10.8mg/dL, 𝑃 < 0.01). When compared by position, at both
pre- and postseason testing, LM had higher body weight,
higher body fat percent, lower HDL levels, and lower VO
2max
levels, all suggesting an inferior cardiovascular profile. After
completion of the season, the LM group had an increase in
HDL (32.2±9.5 to 39.0±9.0mg/dL,𝑃 < 0.01) and triglyceride
levels (107.6 ± 69 to 126.3 ± 83.2mg/dL, 𝑃 < 0.05), and the
NLM group had a decrease in body weight (84.5 ± 4.9 to
83.2 ± 4.6 kg, 𝑃 < 0.05) and fasting glucose levels (89.7 ± 6.0
to 86.7 ± 6.9mg/dL, 𝑃 < 0.05).
4. Conclusion
This is the first report of cardiovascular health, vascular
function, and 24-hour ABP levels in a group of Division III
athletes. We found thicker carotid artery IMT levels, higher


































































Figure 1: Comparison of systolic blood pressure levels between
control (solid bars) and football players (open bars). Significance:
∗
𝑃 < 0.05 compared to control group.
lower VO
2max levels in football players when compared to
controls. When football players were compared by position,
we found that no difference exists in percent FMD or in
carotid artery IMT. Finally, we confirm for the first time in
Division III football players, what other studies [24, 25] have
shown, LM are heavier and less fit compared to NLM.
Limited research evaluates the effect of fitness on com-
mon carotid IMT in athletes, and to the best of our knowledge
no study has reported IMT measures in Division III football
players. It has been shown [26] that otherwise healthy adults
with lower cardiorespiratory fitness have higher IMT val-
ues, suggesting subclinical atherosclerosis. We found similar
results in our study in both LM and NLM, suggesting that
football players, regardless of position, may have increased
risk for atherosclerosis. One study [27] reported that carotid
artery IMT was higher in young professional football players
compared to controls and concluded that the increased IMT
in athletes may be the result of intermittent exposure to
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elevated arterial pressures during exercise, leading to elevated
carotid wall stress. However, a separate study [17] reported no
significant differences in carotid artery IMT levels between
professional football players and inactive controls.The varied
findings related to fitness and IMT in athletes could be related
to differences in training programs; thus further studies are
needed. On the other hand, the effect of BP on carotid artery
IMT is established, and it is known that increasedBP is related
to higher common carotid IMT values [28]. We are the first
to confirm this in Division III football players.
In our study, there was no difference between the groups
in FMD or FMD/shear levels. Traditionally, a diminished
FMD response has been associated with reduced physical
activity and increased risk of CVD. Dobrosielski et al. [8]
compared CVD risk factors, cardiovascular structure, and
function between Division I football players (stratified by
position) and controls. Dobrosielski et al. reported no signifi-
cant difference in FMD between LM, NLM, and controls. We
confirmed their findings in a group of Division III football
players.
Research [3] reports 19.2% prevalence of hypertension
and 61.9% prevalence of prehypertension in collegiate foot-
ball players. According to the AHA, [29] preparticipation
screening exams should identify cardiovascular risk related
to physical activity. These exams include measures of heart
rate, height, weight, and a clinic BP; yet, this data is not
enough to protect athletes from cardiac incidents. Current
recommendations [2] for accurate assessment of BP-related
cardiovascular risk include 24-hour ABP as an adjunct to
clinic BPmeasures, yet many athletic programs do not screen
athletes with ABP monitoring. We are the first to report 24-
hour ABP levels in a group of collegiate athletes. We found
that 24-hour average, daytime, and nighttime systolic BP was
higher in football players compared to the control group,
which could be related to increased CVD risk. A recent study
[30] in professional football players also found a reduced
nighttime drop in BP in many of the players. Therefore,
ABP monitoring along with clinic BP may be important.
Other studies [7] have found that BP increases over a season
in Division I players. When examining changes over the
collegiate season, we found no change in clinic BP from pre-
to postseason testing.
Future studies should further examine ABP and how
clinic BP levels change in collegiate football players of all
divisions. Other future studies should examine vascular
health inDivision III athletes to confirmour findings. Finally,
given the large difference in body weight between positions,
potential for metabolic syndrome should be considered and
examined.
The limitations of our study are related to the participant
population and sample size. Althoughwematched the control
population to the athletes by number of exercise sessions
per week, the participants may not accurately represent a
comparable control for the football players, considering the
type of exercise that football players undergo. The study
sample size overall was small, but this was due to time
restraints to get all player testing done in a set time-frame.
Also, the sample was derived from one small Division III col-
lege, which may not be representative of all football athletes.
These limitations emphasize the need for a further, larger
study that assesses surrogate markers of vascular health and
cardiovascular risk alongwith other cardiovascular outcomes
in collegiate athletes.
In conclusion, collegiate football players may be at
increased risk for impaired cardiovascular or vascular health,
and Division III athletes are a large collegiate population of
athletes who remain understudied. This is the first report of
vascular function, cardiovascular health, and 24-hour ABP
levels in a group of Division III football players. Compared
to active controls, football players have thicker carotid artery
IMT levels, higher systolic BP at all measurement points,
higher body fat, and lower VO
2max levels in football players
when compared to controls. Also, we confirm for the first
time in Division III football players, what other studies have
shown in professional football players and collegiate Division
I players, LM are heavier and less fit compared to fitness
matched controls.
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